The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyun Kuk | - |
dc.contributor.author | Tantry, Udaya S. | - |
dc.contributor.author | Smith, Sidney C., Jr. | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Park, Seung-Jung | - |
dc.contributor.author | Kim, Moo Hyun | - |
dc.contributor.author | Lim, Do-Sun | - |
dc.contributor.author | Shin, Eun-Seok | - |
dc.contributor.author | Park, Duk-Woo | - |
dc.contributor.author | Huo, Yong | - |
dc.contributor.author | Chen, Shao-Liang | - |
dc.contributor.author | Bo, Zheng | - |
dc.contributor.author | Goto, Shinya | - |
dc.contributor.author | Kimura, Takeshi | - |
dc.contributor.author | Yasuda, Satoshi | - |
dc.contributor.author | Chen, Wen-Jone | - |
dc.contributor.author | Chan, Mark | - |
dc.contributor.author | Aradi, Daniel | - |
dc.contributor.author | Geisler, Tobias | - |
dc.contributor.author | Gorog, Diana A. | - |
dc.contributor.author | Sibbing, Dirk | - |
dc.contributor.author | Lip, Gregory Y. H. | - |
dc.contributor.author | Angiolillo, Dominick J. | - |
dc.contributor.author | Gurbel, Paul A. | - |
dc.contributor.author | Jeong, Young-Hoon | - |
dc.date.accessioned | 2022-03-03T22:40:55Z | - |
dc.date.available | 2022-03-03T22:40:55Z | - |
dc.date.created | 2022-02-09 | - |
dc.date.issued | 2021-04 | - |
dc.identifier.issn | 0340-6245 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/137672 | - |
dc.description.abstract | East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y (12) receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | GEORG THIEME VERLAG KG | - |
dc.subject | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject | CLOPIDOGREL PLATELET REACTIVITY | - |
dc.subject | EXPERT CONSENSUS STATEMENT | - |
dc.subject | DUAL ANTIPLATELET THERAPY | - |
dc.subject | CAROTID-ARTERY-DISEASE | - |
dc.subject | ATRIAL-FIBRILLATION | - |
dc.subject | RACIAL-DIFFERENCES | - |
dc.subject | CLINICAL-OUTCOMES | - |
dc.subject | STENT THROMBOSIS | - |
dc.subject | MYOCARDIAL-INFARCTION | - |
dc.title | The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, Do-Sun | - |
dc.identifier.doi | 10.1055/s-0040-1718729 | - |
dc.identifier.scopusid | 2-s2.0-85096095586 | - |
dc.identifier.wosid | 000588002900001 | - |
dc.identifier.bibliographicCitation | THROMBOSIS AND HAEMOSTASIS, v.121, no.04, pp.422 - 432 | - |
dc.relation.isPartOf | THROMBOSIS AND HAEMOSTASIS | - |
dc.citation.title | THROMBOSIS AND HAEMOSTASIS | - |
dc.citation.volume | 121 | - |
dc.citation.number | 04 | - |
dc.citation.startPage | 422 | - |
dc.citation.endPage | 432 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | ATRIAL-FIBRILLATION | - |
dc.subject.keywordPlus | CAROTID-ARTERY-DISEASE | - |
dc.subject.keywordPlus | CLINICAL-OUTCOMES | - |
dc.subject.keywordPlus | CLOPIDOGREL PLATELET REACTIVITY | - |
dc.subject.keywordPlus | DUAL ANTIPLATELET THERAPY | - |
dc.subject.keywordPlus | EXPERT CONSENSUS STATEMENT | - |
dc.subject.keywordPlus | MYOCARDIAL-INFARCTION | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | RACIAL-DIFFERENCES | - |
dc.subject.keywordPlus | STENT THROMBOSIS | - |
dc.subject.keywordAuthor | antiplatelet therapy | - |
dc.subject.keywordAuthor | bleeding risk | - |
dc.subject.keywordAuthor | direct oral anticoagulants | - |
dc.subject.keywordAuthor | ischemic risk | - |
dc.subject.keywordAuthor | race | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.